Quantum Biopharma (QNTM) Return on Capital Employed (2024 - 2026)
Quantum Biopharma (QNTM) posted Return on Capital Employed of 450.31% for Q1 2026, up 294.18% sequentially from 231.9% in Q4 2025, and up 68255.0% YoY from N/an in Q1 2025.
Quantum Biopharma (QNTM) Return on Capital Employed (2024 - 2026) Analysis & Trends
Quantum Biopharma has reported Return on Capital Employed for 3 years, with the latest figure at 450.31% in Q1 2026.
- Quarterly Return on Capital Employed rose 68255.0% year-over-year to 450.31% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 450.31% (up 68255.0% YoY) and the FY2025 annual result came in at 189.34%, down 3737.0% from the prior year.
- Return on Capital Employed rose to 450.31% in Q1 2026 per QNTM's latest filing, from 231.9% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 450.31% in Q1 2026 and troughed at 791.35% in Q2 2025.
- A 3-year average of 204.08% and a median of 231.9% in 2025 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2025 and 2026: Return on Capital Employed sank 12670 bps in 2025, then soared 68255 bps in 2026.
- Over 3 years, Return on Capital Employed stood at 105.2% in 2024, then sank by 120 bps to 231.9% in 2025, then soared by 294 bps to 450.31% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 450.31%, 231.9%, and 185.93% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 20.76% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.74% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -38.20% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.68% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 26.09% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -6.85% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -50.93% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 7.88% |
| 10 | Quantum Biopharma | 15.44 Mn | 11.80 Mn | - | -193.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -193.54% |
| Mar 31, 2026 | 450.31% |
| Dec 31, 2025 | -231.90% |
| Sep 30, 2025 | -185.93% |
| Jun 30, 2025 | -791.35% |
| Mar 31, 2025 | -232.25% |
| Dec 31, 2024 | -105.20% |
| Sep 30, 2024 | -332.21% |